(no title)
patrickhogan1 | 5 months ago
In biomedicine, Amgen could reproduce only 6/53 “landmark” preclinical cancer papers and Bayer reported widespread failures.
patrickhogan1 | 5 months ago
In biomedicine, Amgen could reproduce only 6/53 “landmark” preclinical cancer papers and Bayer reported widespread failures.
No comments yet.